Digital Therapeutics Market Trends 2025 | Most Leading Companies - Teladoc Health, 2Morrow Inc, Omada Health, Inc, Resmed Inc

The Global Digital Therapeutics Market reached US$ 5.7 billion in 2023 and is expected to reach US$ 27.3 billion by 2031, growing at a CAGR of 21.6% during the forecast period 2024-2031.

The Digital Therapeutics Market report, released by DataM Intelligence, offers comprehensive insights and thorough analysis of major market trends, growth prospects, and emerging challenges. With a strong focus on actionable intelligence, DataM Intelligence equips businesses with the knowledge needed to make strategic decisions and maintain a competitive advantage. Utilizing a blend of qualitative and quantitative research methodologies, the firm delivers in-depth reports that support clients in understanding complex market dynamics, fostering strategic development, and capturing new opportunities in today's rapidly changing global environment.

Request a Premium Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/digital-therapeutics-market?kb

Evolving Market Forces and Opportunities:

Digital Therapeutics (DTx) are evidence-based therapeutic interventions delivered through software programs to prevent, manage, or treat medical disorders and diseases. Unlike general wellness apps, DTx products are clinically validated, regulated, and often prescribed by healthcare providers to treat conditions like diabetes, depression, insomnia, ADHD, and more. They often work alongside medications or as standalone treatments.

Key Industry Players Driving the Digital Therapeutics Market:

Teladoc Health, 2Morrow Inc, Omada Health, Inc, Resmed Inc , Voluntis, Inc, Kaia Health, Biofourmis, Click Therapeutics, Inc, Welldoc's BlueStar, Lark Technologies, Inc among others.

Emerging Players

The emerging players in the digital therapeutics market include Happify Health, Cognoa, Propeller Health, Akili Interactive Labs and among others.

Industry Development:

In August 2024, Otsuka Precision Health and Click Therapeutics launched Rejoyn, a prescription digital therapeutic designed to treat symptoms of major depressive disorder. Cleared by the FDA in March 2024, Rejoyn is intended to be used alongside clinician-managed outpatient care for adults aged 22 and older who are currently taking antidepressant medication.

Research Methodology:

Both primary and secondary data sources have been used in the global Digital Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/digital-therapeutics-market?kb

Segment Covered in the Digital Therapeutics Market:

By Product Type: Software, Devices, Others

By Application: Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Diseases, Respiratory Diseases, Smoking Cessation, Gastrointestinal Disorders (GID), Others

By Sales Channel: Business-to-Business (B2B) (Employer, Healthcare Providers, Payers, Pharmaceutical Companies, Others), Business-to-Consumer (B2C) (Patient, Caregiver)

Regional Overview for Digital Therapeutics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/digital-therapeutics-market?kb

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Digital Therapeutics market?

➠ Who are the leading manufacturers in the global Digital Therapeutics industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Digital Therapeutics industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Digital Therapeutics market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.